Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Baylor Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins